Generics 4

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Ciprofibrate manufacturers

4 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

4 products found

ciprofibrate

Tablets 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20848
This pharmaceutical company is a technology-driven enterprise with a focus on product quality and timely delivery. Its ultra-modern, WHO and GMP-certified manufacturing facility is located in a pollution-free industrial estate near major SEZ hubs in Asia. The company exports its products to Southeast Asia, Africa, the CIS region, Latin America & Central America, and the GCC. They supply prescription medications and likely over-the-counter drugs, as indicated by their global distribution network. They emphasize a "human approach" to business with trade partners and prioritize ethical production practices.

Manufacturer usually replies in 3 days

ciprofibrate

Tablets 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #36197

Established in 2018, this manufacturer specializes in exporting and manufacturing pharmaceutical active pharmaceutical ingredients (APIs) and finished formulations, including tablets, capsules, pre-filled syringes, dry syrups, creams, ointments, injectables (liquids and powder), eye/ear drops, IV fluids, and surgical products. As a CTD dossier owner and manufacturer, it holds EU/WHO GMP certifications, ensuring compliance with international quality standards. The manufacturer operates advanced production lines adhering to stringent GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed across various regions, including Central America, non-EU Europe, the Middle East, Oceania, South America, and South Asia.

Manufacturer usually replies in nan days

ciprofibrate

Tablets 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Comments
ROW market
Manufacturer #20862
This company is a quality-driven, customer-centric pharmaceutical manufacturer specializing in generic finished dosage formulations. A subsidiary of a multinational group headquartered in Southeast Asia, it boasts an annual turnover exceeding US$150 million and operates as both a contract manufacturer for global MNCs and a producer of its own branded medications. The company emphasizes affordability and accessibility, aiming to meet unmet patient needs. Their focus lies on developing products across multiple therapy areas, utilizing various dosage forms. They possess GMP certifications and hold patents for their products. While primarily based in South Asia, they aim to expand their reach into the EU and North America through strategic partnerships and collaborations.

Manufacturer usually replies in 14 days

Want to see all 4 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible